26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

despecification 225 dextran<br />

with the antigen during antigen presentation. Allelic variation<br />

permits these contact residues to vary, which is one<br />

of the factors in histocompatibility molecule selection of a<br />

particular epitope that is being presented.<br />

despecification<br />

A method for reducing the antigenicity of therapeutic antisera<br />

prepared in one species and used in another. To render<br />

immunoglobulin molecules less immunogenic in a heterologous<br />

recipient, they may be treated with pepsin to remove<br />

the most immunogenic portion of the molecule (i.e., the Fc<br />

fragment) but leave intact the antigen bonding region (i.e.,<br />

F(ab′) 2 fragments) that retain their antitoxic properties. Had<br />

such a treatment been available earlier in the 20th century,<br />

serum sickness induced by horse antitoxin administered to<br />

human patients as a treatment for diphtheria would have<br />

been greatly reduced.<br />

DETC<br />

Dendritic epidermal T cells. Refer to intraepithelial<br />

lymphocytes.<br />

determinant groups<br />

Chemical mosaics found on macromolecular antigens that<br />

induce an immune response. Also called epitopes.<br />

determinant selection model<br />

Concept that immune response variability to a given antigen<br />

among different individuals is attributable to the ability of<br />

each person’s MHC alleles to successfully bind and present<br />

that antigen’s determinants.<br />

determinant spreading<br />

An amplification mechanism in inflammatory autoimmune<br />

disease in which the initial T lymphocyte response<br />

diversifies through induction of T cells against additional<br />

autoantigenic determinants. The response to the original<br />

epitope is followed by intramolecular spreading, the activation<br />

of T lymphocytes for other cryptic or subdominant<br />

self determinants of the same antigen during chronic and<br />

progressive disease; intermolecular spreading involves<br />

epitopes on other unrelated self antigens. A multideterminant<br />

protein antigen has dominant, subdominant, and<br />

cryptic T cell epitopes. The dominant epitopes are most<br />

efficiently processed and presented from native antigen.<br />

By contrast, cryptic determinants are inefficiently<br />

processed and/or presented. Only by immunization with<br />

a peptide that often requires no additional processing<br />

can a response to a cryptic determinant be mounted.<br />

Subdominant determinants fall between these two types.<br />

deuterostomes<br />

Coelomate-derived animals that developed into the vertebrates.<br />

α (1 6)<br />

linkage<br />

Glucose<br />

α (1 3)<br />

linkage<br />

α (1–6) linkages and β (1–3) linkages in dextran molecule.<br />

dextran<br />

Polysaccharides of high molecular weight comprised of<br />

d-glucohomopolymers with α glycoside linkages, principally<br />

α-1,6 bonds. Dextrans serve as murine B lymphocyte mitogens.<br />

Some dextrans may also serve as thymus-independent<br />

C O<br />

HC R 1<br />

HC R 3<br />

NH<br />

NH<br />

O C<br />

NH<br />

(a) (b)<br />

HC (CH2 ) 4 -N<br />

H<br />

Determinant groups. (a) Conjugated protein with substituents. (b) Broken lines indicate haptenic group. Solid line indicates antigenic determinant.<br />

C O<br />

O 2 N<br />

NO 2<br />

D

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!